Hematopoietic Stem Cell Transplantation for Patients with Severe Sickle Cell Disease Using Myeloablative Conditioning and Alpha Beta T Cell Depleted Hematopoietic Stem Cells From Partially Matched Familial Donors

Gender
Any

Age Group
Any

At a Glance

IRB#IRB19-0640

Lead PhysicianMichele Nassin

Collaborator(s)N/A

EligibilityNot Recruiting